NovoCure Ltd — Director's Dealing 2019

Jan 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-01-09

Reporting Person: Longsworth Todd Christopher (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-09	Ordinary Shares	M	15000	$7.15	Acquired	36305	Direct
2019-01-09	Ordinary Shares	S	15000	$40.15	Disposed	21305	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-09	Options to Buy Ordinary Shares	$7.15	M	15000	Disposed	2027-02-21	Ordinary Shares (15000)	Direct

Footnotes

F1: These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth.

F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Longsworth.

F3: Fully vested and exercisable as of the date hereof.